BioSpace News Archive

Business

Metastatic Breast Cancer Alliance Brings Awareness to Clinical Trials in Advance of the Release of MBC Connect 2.0

National Nonprofit’s Enhanced Mobile App and Online Platform will Potentially Match Patients with Clinical Trials

October 22, 2019
·
7 min read
Deals

Arcutis Announces the Completion of $94.5 million Series C Financing

HBM Healthcare Investments, Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures, and Goldman Sachs join existing investors Frazier Healthcare Partners, Bain Capital Life Sciences, OrbiMed and RA Capital Management

October 22, 2019
·
2 min read
New Research on Climate Change and the Brain, the Relationship Between Stroke and Dementia, Advances in Epilepsy and MS Among the Brain Health Initiatives Unveiled at 24th World Congress of Neurology

The theme of the 2019 World Congress of Neurology (WCN 2019), Accelerating the Pace of Change, emphasizes the global effort to further neurological healthcare, and serves as a springboard to advance the field of neurology around the globe.

October 22, 2019
·
7 min read
Researchers begin trial of drug to slow progression of neurodegenerative condition Multiple System Atrophy

Researchers at UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology & Neurosurgery are set to test whether a drug can slow progression of the devastating neurodegenerative condition Multiple System Atrophy

October 22, 2019
·
5 min read
FDA

Vertex Wins Approval for Triple Combination Drug Expected to Treat 90% of CF Patients

The U.S. Food and Drug Administration approved a new cystic fibrosis medication that is expected to provide treatment for 90% of patients with this debilitating and life-shortening condition.

October 22, 2019
·
3 min read
·
Alex Keown
CRISPR Prime Editing Even Better and More Precise

CRISPR prime editing would theoretically allow that precise editing without the limitations of base editing.

October 22, 2019
·
3 min read
·
Mark Terry
Policy

FDA Rejects Asserito’s Long-Acting Cosyntropin

Shares of Assertio Therapeutics plunged more than 28% Monday after the company announced the U.S. Food and Drug Administration rejected an injectable formulation of long-acting cosyntropin.

October 22, 2019
·
2 min read
·
Alex Keown
Biotech Bay

New Synthego Program Provides Unprecedented Editing of iPS

Genome engineering company Synthego launched a new genome editing program to include induced pluripotent stem cells, adult cells that can be reprogrammed and provide researchers with an easier pathway to drug development.

October 22, 2019
·
2 min read
·
Alex Keown
Business

5 Baby Boomer Biotech Influencers

Here are some of the top biotech influences of this generation.

October 22, 2019
·
3 min read
·
Kymberlie Krieger
Career Advice

10 Unexpected Ways to Use Cover Letters

Here are 10 ideas for using cover letters in ways you may not have thought of.

October 22, 2019
·
6 min read
·
Katharine Hansen, PhD